US Patent

US9199977 — Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal

Composition of Matter · Assigned to Pola Pharma Inc · Expires 2033-09-06 · 7y remaining

Vulnerability score 4/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects a crystal of luliconazole with a specific crystal habit that improves its solubility.

USPTO Abstract

An object is to provide means for improving the solubility of luliconazole. Disclosed is a crystal of luliconazole wherein the crystal has such a crystal habit that (021) plane is a specific crystal growth plane.

Drugs covered by this patent

Patent Metadata

Patent number
US9199977
Jurisdiction
US
Classification
Composition of Matter
Expires
2033-09-06
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Pola Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.